Obituary: David Morris Kern / Pharmaceutical career led to his creating Orajel

Died May 5, 2013

Share with others:


Print Email Read Later

The creator of Orajel, a medicine aimed at fighting toothaches that was later also used for mouth sores, has died, family members said Sunday. David Morris Kern was 103.

Allan Kern, his son, said his father died Friday at a group home in Paradise Valley, Ariz.

Born in 1909 in Manhattan and raised in Brooklyn, Mr. Kern graduated from the Brooklyn College of Pharmacy and worked as a pharmacist before becoming a salesman for Norwich and Warner Pharmaceuticals. After buying a pharmaceutical manufacturing facility with his brother and two partners, he created Orajel with the help of a chemistry professor. Mr. Kern would later tell family members that he developed Orajel because he sought to find relief for teething babies.

"It was the No. 1 product for toothaches for years," Allan Kern said.

The elder Kern later sold the company to Del Laboratories in 1961, and moved to the Phoenix-area in 1990s with his wife, Rose. The couple were married for 65 years until her death in 2001.

Mr. Kern retired from his pharmaceutical career at 62 and later turned to managing family finances, Allan Kern said.

Daughter-in-law Carol Kern said that in retirement Mr. Kern bragged that he had great genes that allowed him to live past 100 years.

"I said during a toast on his 100th birthday that he'd say his secret to a long life was having a martini every day and not eating green vegetables," she said.

"If you are optimistic, and feel young, you will always look and remain young," Mr. Kern told The Arizona Republic in a 2009 interview. "Take advantage of every day."

obituaries - nation - health


Advertisement
Advertisement
Advertisement

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here